Table 2

Characteristics of Phase 1 Study Patients Who Completed and Did Not Complete AOBP Measurements, at Baseline

CharacteristicPatients Who Completed AOBP (n=475)Patients Who Did Not Complete AOPB (n=957)P Value
Age, median y (IQR)54.4 (44.5–64.9)50.1 (38.9–60.4)<.01
Blood pressure, mean mm Hg (SD)
 Systolic136.5 (9.35)136.1 (9.76).46
 Diastolic82.3 (7.05)82.5 (7.25).52
BMI, median kg/m2 (IQR)29.6 (26.3–33.8)30.1 (26.1–34.6).13
Sex, female, No. (%)226 (47.6)459 (48).89
Ethnicity, No. (%).36
 African American29 (6.1)42 (4.4)
 Asian13 (2.7)26 (2.7)
 White337 (70.9)655 (68.5)
 Hispanic/Latino16 (3.4)42 (4.4)
 Other80 (16.8)192 (20.1)
GERD, No. (%)72 (15.2)129 (13.5).39
Asthma, No. (%)36 (7.6)104 (10.9).05
Depression, No. (%)36 (7.6)75 (7.8).89
Diabetes mellitus, No. (%)29 (6.1)62 (6.5).77
COPD, No. (%)10 (2.1)16 (1.7).59
Coronary artery disease, No. (%)5 (1.1)13 (1.4).64
Congestive heart failure, No. (%)2 (0.4)7 (0.7).49
Prior myocardial infarction, No. (%)1 (0.2)2 (0.2).99
  • AOPB =ambulatory office blood pressure; PBMI = body mass index; COPD = chronic obstructive pulmonary disease; GERD = gastroesophageal reflux disease; IQR = interquartile range.